---
layout: post
title: "Determination That MYSOLINE (Primidone) Suspension, 250 Milligrams/5 Milliliters, Was Withdrawn From Sale for Reasons of Safety or Effectiveness"
date: 2026-02-04 21:02:22 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-24196
original_published: 2026-01-02 00:00:00 +0000
significance: 8.00
---

# Determination That MYSOLINE (Primidone) Suspension, 250 Milligrams/5 Milliliters, Was Withdrawn From Sale for Reasons of Safety or Effectiveness

**Published:** February 04, 2026 21:02 UTC
**Source:** Federal Register
**Original Published:** January 02, 2026 00:00 UTC
**Document Number:** 2025-24196

## Summary

The Food and Drug Administration (FDA, Agency, or we) has determined that MYSOLINE (primidone) suspension, 250 milligrams (mg)/5 milliliters (mL), was withdrawn from sale for reasons of safety or effectiveness. The Agency will not accept or approve abbreviated new drug applications (ANDAs) for primidone suspension, 250 mg/5 mL.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2026/01/02/2025-24196/determination-that-mysoline-primidone-suspension-250-milligrams5-milliliters-was-withdrawn-from-sale)
- API: https://www.federalregister.gov/api/v1/documents/2025-24196

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
